title: Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycolide) film: in vitro and in vivo studies.
abstract: Cytarabine (ara-C) was included in albumin microspheres and these microspheres were immersed in a poly(lactide-co-glycolide) (PLGA) film to constitute a comatrix system to develop a prolonged form of release. Cytarabine-loaded albumin microspheres were synthesized by emulsion, and 25 or 50 mg of drug were included in the disperse phase. Thus, microspheres with 46+/-4 microg drug/mg microspheres and 50+/-5 microg drug/mg microspheres were obtained, which means a percentage of incorporation efficiency of 42+/-4% and 25+/-2%, respectively. These cytarabine-loaded microspheres were used to prepare PLGA-comatrices. Kinetic release studies indicated that total cytarabine release only takes place in the presence of protease, probably due to the fact that glutaraldehyde establishes covalent links with the amine side group of the drug and cross-links it with the protein matrix. A slower kinetic release of the drug was obtained from PLGA-comatrices, although only 80% of the included cytarabine was released on day 7. The comatrices were subcutaneously implanted in the back of rats and in both cases the ara-C administered dose was 36 mg of ara-C per kg of body weight. The drug was detected in plasma 10 days. The mean residence time (MRT) of the drug administered by these comatrices was 87-91 times larger when compared to the value obtained when the drug was administered in solution by intraperitoneal injection. The histological studies show that a degradative process of the comatrices takes place. The comatrices do not damage surrounding tissue; a normal regeneration of the implanted zone was observed.
authors.affiliation: Departamento de Bioquímica y Biología Molecular, Universidad Complutense de Madrid, Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Gómez
authors.forename: M D
authors.initials: MD
authors.lastname: Blanco
authors.forename: M V
authors.initials: MV
authors.lastname: Bernardo
authors.forename: R
authors.initials: R
authors.lastname: Olmo
authors.forename: E
authors.initials: E
authors.lastname: Muñiz
authors.forename: J M
authors.initials: JM
authors.lastname: Teijón
mesh_terms: D000818:Animals; D003561:Cytarabine / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D008297:Male; D008863:Microspheres; D011098:Polyglactin 910 / Q000737:chemistry / Q000493:pharmacokinetics*; D051381:Rats; D017208:Rats, Wistar; D012710:Serum Albumin, Bovine / Q000737:chemistry / Q000493:pharmacokinetics*
chemical_list: D003561:Cytarabine; D012710:Serum Albumin, Bovine; D011098:Polyglactin 910